Allen Lutz's Stock Ratings

B of A Securities Analyst

Allen Lutz is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024

Overall Average Return

11.7%

Smart Score

66.2%

Overall Average Return Percentile

66th

Number of Ratings

16
Buy NowGet Alert
07/03/2024HQYBuy Now
HealthEquity
$81.5728.72%$105 → $105MaintainsBuyGet Alert
07/02/2024WAYBuy Now
Waystar Holding
$21.2227.24% → $27Initiates → BuyGet Alert
06/28/2024WBABuy Now
Walgreens Boots Alliance
$10.841.48%$22 → $11ReiteratesUnderperform → UnderperformGet Alert
06/04/2024HQYBuy Now
HealthEquity
$81.5728.72%$97 → $105MaintainsBuyGet Alert
05/14/2024TDOCBuy Now
Teladoc Health
$9.2845.47%$16.5 → $13.5MaintainsNeutralGet Alert
03/20/2024HQYBuy Now
HealthEquity
$81.5718.92%$93 → $97MaintainsBuyGet Alert
01/23/2024DOCSBuy Now
Doximity
$27.1817.73%$29 → $32MaintainsNeutralGet Alert
01/02/2024DOCSBuy Now
Doximity
$27.186.7%$21 → $29UpgradeUnderperform → NeutralGet Alert
08/15/2023DHBuy Now
Definitive Healthcare
$5.3695.9%$12 → $10.5MaintainsNeutralGet Alert
05/05/2023DHBuy Now
Definitive Healthcare
$5.36105.22% → $11MaintainsNeutralGet Alert
01/04/2023AMWLBuy Now
American Well
$0.341139.3% → $4.2UpgradeNeutral → BuyGet Alert
09/30/2022OWLTBuy Now
Owlet
$3.90-61.54% → $21Initiates → NeutralGet Alert
09/09/2022OMCLBuy Now
Omnicell
$26.34355.58% → $120Initiates → BuyGet Alert
08/05/2022DOCSBuy Now
Doximity
$27.186.7%$43 → $29DowngradeNeutral → UnderperformGet Alert
06/23/2022BBLNBuy Now
Babylon Holdings
—— → $50Initiates → NeutralGet Alert
04/04/2022DOCSBuy Now
Doximity
$27.18102.35% → $55Initiates → NeutralGet Alert

Recent Analyst Stock Rating News

Analysts Rally Behind Waystar: Predict Robust Growth and Market Share Gains Following Competitor Setback
Waystar Holding Corp. garners bullish analyst coverage on growth prospects fueled by market demand, competitive advantages, and post-cyberattack opportunities.
Demystifying HealthEquity: Insights From 11 Analyst Reviews
A Glimpse Into The Expert Outlook On HealthEquity Through 13 Analysts
6 Analysts Assess Doximity: What You Need To Know
What 6 Analyst Ratings Have To Say About Doximity
Forecasting The Future: 5 Analyst Projections For Doximity
NVIDIA To Rally More Than 23%? Here Are 10 Other Analyst Forecasts For Tuesday
B of A Securities lowered the price target for Valero Energy Corporation (NYSE: BMBL) from $160 to $152. B of A Securities analyst Doug Leggate downgraded the stock from Buy to Neutral. Valero Energy shares fell 3.3% to $132.00 in pre-market trading.
DoorDash To $129? Here Are 5 Other Price Target Changes For Friday
Citigroup raised the price target on DoorDash, Inc. (NYSE: DASH) from $118 to $129. However, Citigroup analyst Ronald Josey maintained DoorDash with a Buy. DoorDash shares jumped 10.5% to $89.91 in pre-market trading.
Why Do Teladoc Health Investors Stand Divided? Bank Of America Analyst Weighs In
On July 10, Bank of America Corp (NYSE: BAC) analyst Allen Lutz published an analyst note on Teladoc Health, Inc (NYSE: TDOC).
Teladoc Analysts React To Shocking Q1 Losses, Rising BetterHelp Costs
A brutal 12 months for Teladoc Health Inc (NYSE: TDOC) went from bad to much worse on Thursday when the stock dropped another 43% after the company reported much larger-than-expected losses in the first quarter and slashed its 2022 guidance.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free